Market Cap 240.12M
Revenue (ttm) 56.13M
Net Income (ttm) -14.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 28.74
Profit Margin -26.14%
Debt to Equity Ratio 0.97
Volume 165,800
Avg Vol 118,730
Day's Range N/A - N/A
Shares Out 33.26M
Stochastic %K 4%
Beta 0.81
Analysts Strong Sell
Price Target $13.50

Company Profile

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 480 434 6670
Address:
9237 East Via de Ventura Boulevard, Suite 105, Scottsdale, United States
buymoremakemore
buymoremakemore Mar. 15 at 7:24 PM
$DERM Almost daily there is more positive news on Emrosi about its effectiveness. It seems that people have tried many things that did not work and now they've found Emrosi. What I've seen is that people will need to keep taking Emrosi for their skin to continue to be clear, which means more money for Journey. The continued elevated prescription volume is an indication of effectiveness and demand, which historically is a catalyst for insurance companies to cover a drug more favorably. It's not too late to get buy in. https://www.reddit.com/r/perioraldermatitis/comments/1rt2gbx/has_anyone_had_success_with_emrosi_minocycline/
0 · Reply
SylviaAmbriza
SylviaAmbriza Mar. 15 at 4:42 PM
$CVKD Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes https://www.stocktitan.net/news/CVKD/cadrenal-therapeutics-highlights-research-supporting-12-lox-mbmap9qco4op.html $DUOT $DERM $HPK $MNST
0 · Reply
buymoremakemore
buymoremakemore Mar. 15 at 3:47 PM
$DERM This woman’s dermatologist was able to get Emrosi covered by insurance. It’s only inevitable for more people to be covered for emrosi by insurance. As the empirical evidence of its superiority is spread, dermatologists will overwhelm insurance companies with claims DEMANDING Emrosi be covered. It has to been on the market for a year. It’s coming.
0 · Reply
buymoremakemore
buymoremakemore Mar. 14 at 12:46 AM
$DERM The prescriptions and results are coming in. Steal at this price.
0 · Reply
Tomasini
Tomasini Mar. 13 at 6:27 PM
$DERM holy shit. loading at 7.20 some low volume shorting going on
0 · Reply
Tomasini
Tomasini Mar. 13 at 4:23 PM
$DERM time to buy at 7.50. dirt cheap
0 · Reply
Biotech_Beast
Biotech_Beast Mar. 12 at 11:01 AM
$DERM Recently entered this name. Think Emrosi will help drive upside.
0 · Reply
flyinghollaender
flyinghollaender Mar. 5 at 4:54 PM
$FBIO $DERM loading zone
0 · Reply
Tomasini
Tomasini Mar. 5 at 4:38 PM
$DERM wow. a steal under 8. looks like a little shorting going on
0 · Reply
FinSUN
FinSUN Mar. 4 at 2:39 PM
0 · Reply
Latest News on DERM
Top 3 Health Care Stocks That May Crash In Q2

Apr 7, 2025, 11:23 AM EDT - 1 year ago

Top 3 Health Care Stocks That May Crash In Q2

ALMS CMRX


buymoremakemore
buymoremakemore Mar. 15 at 7:24 PM
$DERM Almost daily there is more positive news on Emrosi about its effectiveness. It seems that people have tried many things that did not work and now they've found Emrosi. What I've seen is that people will need to keep taking Emrosi for their skin to continue to be clear, which means more money for Journey. The continued elevated prescription volume is an indication of effectiveness and demand, which historically is a catalyst for insurance companies to cover a drug more favorably. It's not too late to get buy in. https://www.reddit.com/r/perioraldermatitis/comments/1rt2gbx/has_anyone_had_success_with_emrosi_minocycline/
0 · Reply
SylviaAmbriza
SylviaAmbriza Mar. 15 at 4:42 PM
$CVKD Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes https://www.stocktitan.net/news/CVKD/cadrenal-therapeutics-highlights-research-supporting-12-lox-mbmap9qco4op.html $DUOT $DERM $HPK $MNST
0 · Reply
buymoremakemore
buymoremakemore Mar. 15 at 3:47 PM
$DERM This woman’s dermatologist was able to get Emrosi covered by insurance. It’s only inevitable for more people to be covered for emrosi by insurance. As the empirical evidence of its superiority is spread, dermatologists will overwhelm insurance companies with claims DEMANDING Emrosi be covered. It has to been on the market for a year. It’s coming.
0 · Reply
buymoremakemore
buymoremakemore Mar. 14 at 12:46 AM
$DERM The prescriptions and results are coming in. Steal at this price.
0 · Reply
Tomasini
Tomasini Mar. 13 at 6:27 PM
$DERM holy shit. loading at 7.20 some low volume shorting going on
0 · Reply
Tomasini
Tomasini Mar. 13 at 4:23 PM
$DERM time to buy at 7.50. dirt cheap
0 · Reply
Biotech_Beast
Biotech_Beast Mar. 12 at 11:01 AM
$DERM Recently entered this name. Think Emrosi will help drive upside.
0 · Reply
flyinghollaender
flyinghollaender Mar. 5 at 4:54 PM
$FBIO $DERM loading zone
0 · Reply
Tomasini
Tomasini Mar. 5 at 4:38 PM
$DERM wow. a steal under 8. looks like a little shorting going on
0 · Reply
FinSUN
FinSUN Mar. 4 at 2:39 PM
0 · Reply
Tomasini
Tomasini Mar. 3 at 5:22 PM
$DERM does mgt ever do anything?
0 · Reply
flyinghollaender
flyinghollaender Feb. 28 at 2:05 AM
1 · Reply
Tomasini
Tomasini Feb. 27 at 10:37 PM
$DERM Hugh drop last hour. No news? Pretty strange but must have been shorting
0 · Reply
crazysnake
crazysnake Feb. 27 at 8:30 PM
$FBIO just the 40% equity in $DERM they own is more then the marker cap add to it equity in 6 other companys and 180 million in cash after prv money comes who is sellimg this under 10$ ?
1 · Reply
Tomasini
Tomasini Feb. 27 at 4:15 PM
$DERM somebody unloaded 40000 shares at 8.3
0 · Reply
Tomasini
Tomasini Feb. 27 at 3:51 PM
$DERM somebody just unloaded 40000 shares at 8.3
0 · Reply
omega42
omega42 Feb. 27 at 12:25 AM
$DERM some are banking on derm comming short of results. for me it is very encouraging given what we know about the q4 scripts and the fact they may turn profit. coul dbe a voilent shakeout for teh sp and strong movement upwards.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 25 at 11:12 AM
$DERM Current Stock Price: $8.71
0 · Reply
omega42
omega42 Feb. 25 at 1:16 AM
$DERM Q4 will be $7.5-8.5M of Emrosi revenue which is about 26-29k of scripts at $270 per script. $12-14 per share after Q4 report announcement in mid march....BOOM!!!
3 · Reply
Tomasini
Tomasini Feb. 24 at 4:41 PM
$DERM anyone have a clue hoe Emrosi sales are doing?
1 · Reply
TriggerCrafter
TriggerCrafter Feb. 18 at 10:33 AM
$DERM Dermatology-focused biotech with commercialization hurdles.
1 · Reply
FadeMonitor
FadeMonitor Feb. 18 at 7:12 AM
$DERM DermTech provides non-invasive skin cancer genomics tests, facing slow commercial adoption and reimbursement challenges [citation:historical].
1 · Reply